Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Gregory A. Roth, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 8.7K citations · Full text

Public Health, Health Sciences, Population Health Sciences +17

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

Ronán Conroy · European Heart Journal · 2003 · 5.3K citations · Full text

Medicine, Cardiology, Risk Management +17

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology · 2016 · 4.8K citations

Medicine, Internal Medicine, Hepatology +9

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen et al. · Gastroenterology · 2015 · 3K citations · Full text

Medicine, Internal Medicine, Pathology +12

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.3K citations · Full text

Medicine, Internal Medicine, Pathology +17